×

----2019~20------
1: Kim JY, Lee Y, Choe BH, Kang B. Factors Associated with the Immunogenicity of Anti-Tumor Necrosis Factor Agents in Pediatric Patients with Inflammatory Bowel Disease. Gut Liver. 2020 Oct 8. Epub ahead of print.

2: Kim G, Bae J, Choe BH, Kang B, et al. Delayed Establishment of Gut Microbiota in Infants Delivered by Cesarean Section. Front Microbiol. 2020 Sep 11;11:2099.

3: Paek EY, Yi DY, Kang B, Choe BH. Fecal calprotectin as a marker of gastrointestinal involvement in pediatric Henoch-Schonlein purpura patients: a retrospective analysis. BMC Pediatr. 2020 Aug 8;20(1):374.

4: Choe BH. Safety and Competency are the Main Priorities in Pediatric Endoscopy. Clin Endosc. 2020 Jul;53(4):379-380.

5:Lee K, Choe BH, Kang B, Yang HR,et al. Nationwide Multicenter Study of Eosinophilic Esophagitis in Korean Children. Pediatr Gastroenterol Hepatol Nutr. 2020 May;23(3):231-242.
등 13개

----2018 이전------

1. Characteristics and Incidence Trends for Pediatric Inflammatory Bowel Disease in Daegu-Kyungpook Province in Korea: a Multi-Center Study. J Korean Med Sci. 2018 Apr 12;33(18):e132.

2: What Are the Main Differences in the Treatment of Chronic Hepatitis B between Korean Children and Adults
J Korean Med Sci. 2018 Feb 19;33(8):e69.

3: A Multicenter Study of the Antiviral Efficacy of Entecavir Monotherapy Compared to Lamivudine Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B. J Korean Med Sci. 2018 Feb 19;33(8):e63.

4: Antiviral Efficacy of Tenofovir Monotherapy in Children with Nucleos(t)ide-naive Chronic Hepatitis B. J Korean Med Sci. 2018 Jan 8;33(2):e11.

5: Epidemiological Correlation between Fecal Adenovirus Subgroups and Pediatric Intussusception in Korea. J Korean Med Sci. 2017 Oct;32(10):1647-1656.
등 23개